Disclosure: The author is long BNRDF. (More…)
- It has been suggested that American investors could be in violation of the Controlled Substance Act. This is debatable since Canadian MMPR medical marijuana is federally legal in Canada.
- Some major U.S. companies violate U.S. federal laws while in different countries (WMT, F, and GM).
- Two international companies, GWPH and BAYRY, currently manufacture and distribute a cannabis medication that would violate the Controlled Substance Act if dispensed within the U.S.
- There are five public MMPR licensed companies – with OGRMF as the first licensed producer – officially listed on an American exchange (OTC markets).
- While American investors might not be at risk of violating U.S. federal law (the Controlled Substance Act), there still exists both considerable potential and risk.
A recent article stated, “according to some U.S. experts … American investors in Canadian medical marijuana can be seen as violating the Controlled Substances Act.” This is a significant issue as it could deeply affect Canadian MMPR stocks and investor relations with the United States. Can investing in completely legal Canadian medical marijuana stocks be illegal for an American investor?